Full Text View
Tabular View
No Study Results Posted
Related Studies
Local Paclitaxel Delivery for SFA Disease (IRRITAX)
This study is not yet open for participant recruitment.
Study NCT00821028.   Last updated on January 20, 2009.
Information provided by University of Oklahoma
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atherosclerosis
Angioplasty
Peripheral Arterial Disease
Additional conditions recognized in this trial
Peripheral Vascular Diseases
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
Paclitaxel
More general drug interventions related to this trial
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
University of Oklahoma


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services